Dear all,
Here are the minutes of the Geuvadis RNAseq analysis group call of March
20. The next call will be in two weeks, April 5th.
*Action items:
*- Berlin should upload the miRNA sample information sheet to the ftp
site asap
- People should send Mathias from Uppsala the RNA quality info that he
has asked for
- Those who want to present on a specific topic at the analysis group
meeting should email Tuuli
- Everyone who wants to be involved in miRNA analysis should send Esther
(esther.lizano(a)crg.es) an email
Data submissions
- All mRNA data is submitted. Tuuli will go through all the files,
checksums and sample info for a final fastq freeze.
- All the miRNA data has been submitted except for Kiel that had
sequencer issues and Munich that postponed the run. We'll proceed with
the analysis of the data that we have thus far (Tuuli will check these
files and sample info as well), and add these missing ~100 samples later.
- Mathias from Uppsala needs RNA quality data of the 5 replicate samples
- please send it to him
Analysis group meeting
- Tuuli will put together a preliminary program. Those who want to
present on a specific topic should send Tuuli an email, otherwise / in
addition there will be 45-60min slots for all the labs to talk about
analysis that they've done/planned. We'll brainstorm the first day and
put together a practical analysis plan on the second day.
miRNA processing
- the Barcelona miRNA pipeline will be used to process (map, quantify)
the miRNAs. They'll start downloading the data as soon as possible.
Tuuli prepare the alternative allele miRNA reference sequences
- People who want to be involved in the miRNA analysis should let Esther
know
mRNA processing
- Micha presented their pipeline for mapping and quantification. The
mapping statistics of Geuvadis samples look good, no huge lab effects.
- the fact that GEM isn't published yet is a problem, and in Manolis's
opinion we should use another mapper if the manuscript is not submitted
by the end of April. Thus far we'll work with the GEM bams, but Tuuli
will check with Natalja if EBI could map everything with bwa as a
precaution.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch